>Title;Jieduquyuziyin prescription suppresses IL-17 production and Th17 activity in MRL/lpr mice by inhibiting expression of Ca(2+)/calmodulin-dependent protein kinase-4.
>Date;09/03/2015
>Journal;J Nat Med
>Conflict;NA
